Evidence-based review of treatment and follow up of pediatric patients with differentiated thyroid carcinoma

Marianna Rachmiel, M. Charron, A. Gupta, J. Hamilton, D. Wherrett, V. Forte, D. Daneman

Research output: Contribution to journalReview articlepeer-review


Childhood onset differentiated thyroid cancer (DTC) is distinct from the adult-onset disease being more aggressive at the time of initial evaluation with a higher risk category for disease recurrence; however, it is ultimately less lethal. International groups have outlined consensus statements detailing follow up and management guidelines for adult DTC, but since disease progression and markers are significantly different in childhood DTC compared to adults, management protocols may differ. Unfortunately, there is no consensus regarding the means of follow up, timing and management strategy regarding pediatric DTC. We performed an evidence-based review of DTC in children targeted to address the following questions: What is the most appropriate initial treatment? What is the goal of thyroid hormone replacement management? What is the approach to follow-up of childhood DTC? and, How should tumor recurrence/persistence be assessed and treated? We conducted a literature search using PubMed, Cochrane databases, guidelines from various international groups, and studies pertaining to pediatric DTC management and outcome in order to answer these questions. We suggest a pre-set algorithm and approach for the management of children with DTC according to our review.

Original languageEnglish
Pages (from-to)1377-1393
Number of pages17
JournalJournal of Pediatric Endocrinology and Metabolism
Issue number12
StatePublished - Dec 2006
Externally publishedYes


  • Children
  • Differentiated thyroid cancer
  • Evidence
  • Review
  • Treatment


Dive into the research topics of 'Evidence-based review of treatment and follow up of pediatric patients with differentiated thyroid carcinoma'. Together they form a unique fingerprint.

Cite this